| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Molecular Pathology* and Gastroenterological Surgery, Tohoku University School of Medicine, Sendai, Japan
We previously found frequent loss of heterozygosity at 12q21 and 12q22-q23.1 in primary pancreatic cancers, and the DUSP6/MKP-3 gene residing in this region at 12q22 lost its expression in the great majority of pancreatic cancer cell lines. The DUSP6/MKP-3 protein is a dual-specificity phosphatase that dephosphorylates the active form of ERK, making a feedback loop to control ERK activity. Gain-of-function mutations of KRAS2 occur in the great majority of pancreatic cancer cells, and loss of expression of DUSP6/MKP-3 may synergistically promote constitutive activation of ERK and uncontrolled cell growth. To study loss of the feedback pathway and its impact on pancreatic cancer cell growth, we first investigated the expression of DUSP6/MKP-3 in primary pancreatic cancer tissues immunohistochemically; we found up-regulation in mildly as well as severely dysplastic/in situ carcinoma cells and down-regulation in invasive carcinoma, especially in the poorly differentiated type. Adenovirus-mediated reintroduction of DUSP6/MKP-3 into cultured pancreatic cancer cells induced strong expression of recombinant DUSP6/MKP-3 and reduction of phosphorylated ERK in a dose-dependent manner based on the multiplicity of infection and resulted in suppression of cell growth. Moreover, analyses by flow cytometry and immunocytochemistry revealed that the exogenous expression of DUSP6/MKP-3 induced apoptosis. These results show that DUSP6 exerts apparent tumor-suppressive effects in vitro and suggest that DUSP6 is a strong candidate tumor suppressor gene at 12q22 locus.
This article has been cited by other articles:
 |
|
 |
|
  D. W. Chan, V. W.S. Liu, G. S.W. Tsao, K.-M. Yao, T. Furukawa, K. K.L. Chan, and H. Y.S. Ngan Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells Carcinogenesis, September 1, 2008; 29(9): 1742 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Morrison, M. K.H. Kim, W. Berkofsky-Fessler, and J. D. Licht WT1 Induction of Mitogen-Activated Protein Kinase Phosphatase 3 Represents a Novel Mechanism of Growth Suppression Mol. Cancer Res., July 1, 2008; 6(7): 1225 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, J. Lagowski, A. Sundholm, A. Sundberg, and M. Kulesz-Martin Microtubule Disruption and Tumor Suppression by Mitogen-Activated Protein Kinase Phosphatase 4 Cancer Res., November 15, 2007; 67(22): 10711 - 10719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Y. Chen, S.-L. Yu, C.-H. Chen, G.-C. Chang, C.-Y. Chen, A. Yuan, C.-L. Cheng, C.-H. Wang, H.-J. Terng, S.-F. Kao, et al. A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer N. Engl. J. Med., January 4, 2007; 356(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Wattenberg Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis Am J Physiol Cell Physiol, January 1, 2007; 292(1): C24 - C32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Masih-Khan, S. Trudel, C. Heise, Z. Li, J. Paterson, V. Nadeem, E. Wei, D. Roodman, J. O. Claudio, P. L. Bergsagel, et al. MIP-1{alpha} (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma Blood, November 15, 2006; 108(10): 3465 - 3471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Shen, J. Wang, J. Wu, V. B. Zhurkin, and Y. Yin Mitogen-Activated Protein Kinase Phosphatase 2: A Novel Transcription Target of p53 in Apoptosis. Cancer Res., June 15, 2006; 66(12): 6033 - 6039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cui, I. Parra, M. Zhang, S. G. Hilsenbeck, A. Tsimelzon, T. Furukawa, A. Horii, Z.-Y. Zhang, R. I. Nicholson, and S. A.W. Fuqua Elevated Expression of Mitogen-Activated Protein Kinase Phosphatase 3 in Breast Tumors: A Mechanism of Tamoxifen Resistance Cancer Res., June 1, 2006; 66(11): 5950 - 5959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. McEwen and M. Peifer Puckered, a Drosophila MAPK phosphatase, ensures cell viability by antagonizing JNK-induced apoptosis Development, September 1, 2005; 132(17): 3935 - 3946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bloethner, B. Chen, K. Hemminki, J. Muller-Berghaus, S. Ugurel, D. Schadendorf, and R. Kumar Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines Carcinogenesis, July 1, 2005; 26(7): 1224 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Powles, R. t. Poele, J. Shamash, T. Chaplin, D. Propper, S. Joel, T. Oliver, and W. M. Liu Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway Blood, February 1, 2005; 105(3): 1214 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chevillard, N. Ugolin, P. Vielh, K. Ory, C. Levalois, D. Elliott, G. L. Clayman, and A. K. El-Naggar Gene Expression Profiling of Differentiated Thyroid Neoplasms: Diagnostic and Clinical Implications Clin. Cancer Res., October 1, 2004; 10(19): 6586 - 6597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Warmka, L. J. Mauro, and E. V. Wattenberg Mitogen-activated Protein Kinase Phosphatase-3 Is a Tumor Promoter Target in Initiated Cells That Express Oncogenic Ras J. Biol. Chem., August 6, 2004; 279(32): 33085 - 33092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Aguirre, C. Brennan, G. Bailey, R. Sinha, B. Feng, C. Leo, Y. Zhang, J. Zhang, J. D. Gans, N. Bardeesy, et al. High-resolution characterization of the pancreatic adenocarcinoma genome PNAS, June 15, 2004; 101(24): 9067 - 9072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ito, S.-i. Tsukumo, N. Suzuki, H. Motohashi, M. Yamamoto, Y. Fujii-Kuriyama, J. Mimura, T.-M. Lin, R. E. Peterson, C. Tohyama, et al. A Constitutively Active Arylhydrocarbon Receptor Induces Growth Inhibition of Jurkat T Cells through Changes in the Expression of Genes Related to Apoptosis and Cell Cycle Arrest J. Biol. Chem., June 11, 2004; 279(24): 25204 - 25210. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
